Reuters logo
BRIEF-Philips demonstrates efficacy of Stellarex .035" low-dose drug-coated balloon in clinical trial at two years
September 14, 2017 / 7:52 PM / 2 months ago

BRIEF-Philips demonstrates efficacy of Stellarex .035" low-dose drug-coated balloon in clinical trial at two years

Sept 14 (Reuters) - Koninklijke Philips Nv:

* Efficacy of Philips’ Stellarex .035” low-dose drug-coated balloon demonstrated in clinical trial at two years

* Koninklijke Philips NV says ‍data shows Stellarex demonstrates higher efficacy and patency results, longer treatment durability compared to uncoated balloon​

* Koninklijke Philips NV -‍ 2 year data from ILLUMENATE EURCT validates durable clinical performance of Stellarex low-dose drug-coated balloon​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below